As previously reported, Sarah Romano resigned as Chief Financial Officer of Kiora Pharmaceuticals, Inc. effective as of February 25, 2022 (the “Effective Date”) to pursue another opportunity. Following Ms. Romano's resignation, the Company appointed Michael Meluzio, CPA, the Corporate Controller of the Company, as the Company's principal financial officer and principal accounting officer, effective as of the Effective Date.